(2R,6R,11R)-3-(2-Hydroxy-2-phenylpropyl)-6,11-dimethyl-1,2,3,4,5,6-hexahydro-2,6-methanobenzo[d]azocin-8-ol

ID: ALA4077833

Chembl Id: CHEMBL4077833

PubChem CID: 137649109

Max Phase: Preclinical

Molecular Formula: C23H29NO2

Molecular Weight: 351.49

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@H]1[C@H]2Cc3ccc(O)cc3[C@]1(C)CCN2CC(C)(O)c1ccccc1

Standard InChI:  InChI=1S/C23H29NO2/c1-16-21-13-17-9-10-19(25)14-20(17)22(16,2)11-12-24(21)15-23(3,26)18-7-5-4-6-8-18/h4-10,14,16,21,25-26H,11-13,15H2,1-3H3/t16-,21+,22+,23?/m0/s1

Standard InChI Key:  NGEGLNLPWZDEEJ-SQEIEAQLSA-N

Alternative Forms

  1. Parent:

    ALA4077833

    ---

Associated Targets(non-human)

OPRK1 Kappa opioid receptor (4577 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRK1 mu/kappa opioid receptor (15 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Oprm1 Mu opioid receptor (6060 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Oprd1 Delta opioid receptor (3911 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 351.49Molecular Weight (Monoisotopic): 351.2198AlogP: 3.82#Rotatable Bonds: 3
Polar Surface Area: 43.70Molecular Species: BASEHBA: 3HBD: 2
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 9.90CX Basic pKa: 10.71CX LogP: 3.58CX LogD: 1.48
Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.88Np Likeness Score: 1.10

References

1. Pasquinucci L, Turnaturi R, Prezzavento O, Arena E, Aricò G, Georgoussi Z, Parenti R, Cantarella G, Parenti C..  (2017)  Development of novel LP1-based analogues with enhanced delta opioid receptor profile.,  25  (17): [PMID:28734666] [10.1016/j.bmc.2017.07.021]

Source